The gastroenterology ASC market had revenues of $7.21 billion in 2019 and has $10.27 billion in its sights for 2027, according to a January market report from Reports Globe.
The firm believes the GI ASC market will grow at a compound annual growth rate of 5.8 percent through 2027.
Key companies in the market include Olympus, Johnson & Johnson, Medtronic, Hill-Rom Holdings, GE Healthcare, Cardinal Health and Boston Scientific.